Caldera Medical Statement Regarding FDA Mesh Announcement

Dear Patients and Medical Professionals: Effective April 16th, 2019, the U.S. Food and Drug Administration (FDA) ordered the only two manufacturers of Transvaginal Pelvic Organ Prolapse (POP) surgical meshes to stop all sales and distribution in the United States. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636114.htm In our aim to support you in your clinical choices, we want to clarify that […]

Vertessa Lite Launch

Caldera Medical Announces FDA Clearance for new generation of Vertessa® Lite Polypropylene Mesh for Sacrocolpopexy Device Maker Continues to Broaden Product Portfolio with a Unique Blue, Lightweight, Flexible yet Strong, Mesh for Sacrocolpopexy. AGOURA HILLS, CA, July 1, 2015 – Caldera Medical, a medical device company leading the development of innovative abdominally placed products for […]